Construction and expression of hepatitis b surface antigen escape variants within the "a" determinant by site directed mutagenesis

Iranian Journal of Immunology

Volumn 10, Issue 3, 2013, Pages 127-138

  Shirazi, Forough Golsaz ^a   Amiri, Mohammad Mehdi ^a   Mohammadi, Hamed ^a   Bayat, Ali Ahmad ^b   Roohi, Azam ^a   Khoshnoodi, Jalal ^a   Zarnani, Amir Hassan ^c   Jeddi Tehrani, Mahmood ^b   Kardar, Gholam Ali ^c,d   Shokri, Fazel ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Monoclonal Antibody Research Center   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

"A" determinant; HBs Ag; Monoclonal antibody

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN CLASS; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIGEN EXPRESSION; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOBLOTTING; IMMUNOREACTIVITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; VIRAL GENE DELIVERY SYSTEM; AMINO ACID SEQUENCE; ANIMAL; CHO CELL LINE; CRICETULUS; GENETICS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CHO CELLS; CRICETULUS; EPITOPES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNE EVASION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; RECOMBINANT PROTEINS;

EID: 84898878083     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dufour DR. Hepatitis B surface antigen (HBsAg) assays-are they good enough for their current uses? Clin Chem. 2006; 52:1457-9
2. Nassal M, Schaller H. Hepatitis B virus replication-an update. J Viral Hepat. 1996; 3:217-26
3. Lam W, Li Y, Liou JY, Dutschman GE, Cheng YC. Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: interaction with deoxynucleoside triphosphates and anti-HBV l-deoxynucleoside analog triphosphates. Mol Pharmacol. 2004; 65:400-6
4. Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci. 2007; 1:62-70
5. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990; 336: 325-9
6. Coleman PF. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis. 2006; 12:198-203
7. Horvat RT. Diagnostic and Clinical Relevance of HBV Mutations. Lab Med. 2011; 42:488-96
8. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology. 1996; 24:489-93
9. Shizuma T, Hasegawa K, Ishikawa K, Naritomi T, Iizuka A, Kanai N, et al. Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus. J Gastroenterol. 2003; 38:244-53
10. Chang MH. Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antivir Ther. 2010; 15:463-9
11. Li F, Zhang C, Liu J, Zhang X, Yan B, Zhang B, et al. Preparation, identification, and clinical application of anti-HBs monoclonal antibody that binds both wild-type and immune escape mutant HBsAgs. Front Med China. 2009; 3:277-83
12. Roohi A, Yazdani Y, Khoshnoodi J, Jazayeri SM, Carman WF, Chamankhah M, et al. Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens. World J Gastroenterol. 2006; 12:5368-74
13. Zola H. Monoclonal antibodies: the second generation. 1st ed. Oxford: BIOS Scientific Publishers; 1995
14. Roohi A, Khoshnoodi J, Zarnani A, Shokri F. Epitope mapping of recombinant hepatitis B surface antigen by murine monoclonal antibodies. Hybridoma. 2005; 24:71-7
15. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol. 2006; 80:2968-75
16. Caligiuri P, Sticchi L, Cerruti R, Icardi G, Bruzzone B. Presence of HBV S-gene mutants in immunocompromised patients. The new microbiologica. 2012; 35:97-8
17. Peng XM, Gu L, Chen XJ, Li JG, Huang YS, Gao ZL. Optimization of competitively differentiated polymerase chain reaction in detection of HBV basal core promoter mutation. World J Gastroenterol. 2005; 11:3614-8
18. Torresi J. Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin. Antivir Ther. 2008; 13:337-40
19. Ie S, Thedja MD, Roni M, Muljono DH. Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors. Virol J. 2010; 7:326
20. Cooreman MP, Van Roosmalen MH, Te Morsche R, Sünnen CM, Schoondermark-van de Ven EM, Jansen JB, et al. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to g145r and other naturally occurring "a" loop escape mutations. Hepatology. 1999; 30:1287-92
21. Bartholomeusz A, Locarnini S. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. Hepatology. 2001; 34:432-5
22. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol. 2005; 32:102-12
23. Amini-Bavil-Olyaee S, Vucur M, Luedde T, Trautwein C, Tacke F. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and-negative strains. J Virol. 2010; 84:1026-33
24. Chen HB, Fang DX, Li FQ, Jing HY, Tan WG, Li SQ. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World J Gastroenterol. 2003; 9:304-8
25. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Férey M-P, Ebel A, et al. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol. 2006; 44:2321-6
26. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997; 4:11-20
27. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer Z, Büschenfelde KH, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology. 1998; 27:254-63
28. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, et al. The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol. 2007; 45:2971-8
29. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol. 2012; 57:720-9
30. Kwei K, Tang X, Lok AS, Sureau C, Garcia T, Li J, et al. Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation. J Virol. 2013; 87:2352-7
31. Jongerius JM, Wester M, Cuypers HT, Oostendorp WR, Lelie PN, van der Poel CL, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion. 1998; 38:56-9
32. Katz L, Paul M, Guy D, Tur-Kaspa R. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis. Transpl Infect Dis. 2010;12:292-308